艾塞那肽缓释微球制剂出口海外金额分析数据

艾塞那肽缓释微球制剂是一种用于治疗2型糖尿病的注射类药物，它属于GLP-1受体激动剂，延缓了药物的吸收时间，大大提高治疗的便利性和患者的依从性。通过采集公司每年每月出口艾塞那肽缓释微球制剂到各个国家的出口金额，计算各个国家每年出口金额的方差大小，用来评价各个国家的出口情况，从而评估行业内企业的生产和出口策略，并且通过往年数据了解本药物在该国的淡旺季，以平衡生产和出口数量。1.数据采集：采集我公司生产的艾塞那肽缓释微球制剂每年每个月出口到各个国家的出口金额（以千美元为单元），并汇总计算得到当年的总出口金额。2.数据处理：根据平均月出口金额=总出口金额/12，以及方差公式计算得到平均月出口金额和方差s^2的值。根据方差s^2对各个国家进行分类评价，当方差s^2＜0.15评价该国为出口超平稳型国家。当0.15≤方差s^2≤0.3评价该国为出口一般平稳型国家。当方差s^2＞0.3评价该国为出口波动型国家。3.数据应用：通过了解该药物各个国家的出口情况，评估行业内企业的生产和出口策略，并通过往年数据了解本药物在该国的淡旺季，以平衡生产和出口数量。

Exenatide extended-release microspheres are an injectable medication for the treatment of type 2 diabetes mellitus. As a GLP-1 receptor agonist, it delays drug absorption, significantly enhancing treatment convenience and patient adherence.

By collecting the monthly export values (in thousands of US dollars) of our company's exenatide extended-release microspheres to various countries, we calculate the variance of the annual export amount for each country to evaluate their export performance. This analysis is used to assess the production and export strategies of enterprises in the industry, and to identify the peak and off-peak seasons of this drug in each country based on historical data, so as to balance production and export volumes.

1. Data Collection: Collect the monthly export values (in thousands of US dollars) of the exenatide extended-release microspheres produced by our company to various countries, and aggregate the data to calculate the total annual export amount.

2. Data Processing: Calculate the average monthly export value (total annual export amount / 12) and the variance s² using the standard variance formula. Classify each country for export performance evaluation based on the value of s²: countries with s² < 0.15 are categorized as ultra-stable export markets; countries with 0.15 ≤ s² ≤ 0.3 are categorized as generally stable export markets; and countries with s² > 0.3 are categorized as volatile export markets.

3. Data Application: Evaluate the production and export strategies of enterprises in the industry by understanding the export performance of this drug in various countries, and identify the peak and off-peak seasons of the drug in each country using historical data, so as to balance production and export volumes.

搜集汇总

数据集介绍

特点

该数据集包含艾塞那肽缓释微球制剂2018年出口海外的月度金额数据，通过计算方差评估各国出口稳定性，旨在帮助企业优化生产和出口策略。